文献速递血栓与止血

肝素诱导性血小板减少症预检诊断评分:基于前瞻性多国数据库的构建与内部验证

Heparin-induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation.
PubMed 文献 · J Thromb Haemost · 2021-06-14

通过多因素分析确定8个与HIT相关的临床特征并赋分构建预检评分,推导队列C统计量为0.79(95%CI 0.76-0.82),验证队列AUC为0.77(95%CI 0.74-0.80)。该评分可能有助于指导HIT诊断检测和抗凝治疗决策。

要点

  • 8个临床特征被纳入HIT预检评分,包括肝素类型、剂量、手术、创伤、血小板下降幅度和时间间隔等。
  • 评分在推导队列C统计量为0.79,验证队列AUC为0.77,具有中等 discriminative 能力。
  • 高概率组HIT患病率接近30%,可能指导临床决策。

核心结论

  • 基于8个客观易收集的临床特征构建的HIT预检评分,可能指导诊断检测和抗凝决策。

研究设计与样本

  • 观察性研究,分析前瞻性收集的疑似HIT住院患者数据(ClinicalTrials.gov NCT00748839)。
  • 共2280例可评估患者,随机分配至推导队列和验证队列。
  • 独立裁决者基于前瞻性数据和5-羟色胺释放试验结果诊断HIT。

主要发现

  • 推导队列中HIT诊断234例(14.7%),验证队列99例(14.5%)。
  • 8个特征与HIT相关并赋分:普通肝素(1分)、治疗剂量肝素(1分)、体外循环心脏手术(2分)、严重创伤(3分)、抗凝启动至疑似HIT间隔5-21天(4分)、血小板计数≤6天内下降≥40%(3分)、动脉血栓事件(3分)、静脉血栓事件(3分)。
  • 推导队列C统计量0.79(95%CI 0.76-0.82)。
  • 验证队列AUC 0.77(95%CI 0.74-0.80)。
  • 高概率组HIT患病率接近30%。

关键数值与推荐

  • 高概率组HIT患病率接近30%。

临床怎么用

  • 对于疑似HIT患者,可使用该预检评分评估HIT概率,指导是否进行实验室检测和初始抗凝管理。

局限性

  • 评分的性能可能取决于临床环境和实践模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diagnosis of heparin-induced thrombocytopenia (HIT) requires pretest probability assessment and dedicated laboratory assays. OBJECTIVE: To develop a pretest score for HIT. DESIGN: Observational; analysis of prospectively collected data of hospitalized patients suspected with HIT (ClinicalTrials.gov NCT00748839). SETTING: Thirty-one tertiary hospitals in France, Switzerland, and Belgium. PATIENTS: Patients tested for HIT antibodies (2280 evaluable), randomly allocated to derivation and validation cohorts. MEASUREMENTS: Independent adjudicators diagnosed HIT based on the prospectively collected data and serotonin release assay results. RESULTS: Heparin-induced thrombocytopenia was diagnosed in 234 (14.7%) and 99 (14.5%) patients in the two cohorts. Eight features were associated with HIT (in brackets, points assigned for score calculation of the score): unfractionated heparin (1); therapeutic-dose heparin (1); cardiopulmonary bypass (cardiac surgery) (2); major trauma (3); 5- to 21-day interval from anticoagulation initiation to suspicion of HIT (4); ≥40% decrease in platelet count over ≤6 days (3); thrombotic event, arterial (3) or venous (3). The C-statistic was 0.79 (95% CI, 0.76-0.82). In the validation cohort, the area under the receiver operating characteristic curve was 0.77 (95% CI, 0.74-0.80). Three groups of scores were defined; HIT prevalence reached almost 30% in the high-probability group. LIMITATION: The performance of the score may depend on settings and practices. CONCLUSION: The objective, easy-to-collect, clinical features of HIT we evidenced were incorporated into a pretest score, which may guide clinical decisions regarding diagnostic testing and anticoagulation.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Tardy-Poncet B, de Maistre E, Pouplard C, et al. Heparin-induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation. J Thromb Haemost. 2021. PMID: 33872452. doi:10.1111/jth.15344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。